Shareholder Information Shares on Issue 126,377,872 Options 6,100,000 Warrants ($1.50) 2,518,600 (Expires April 6, 2020) ($0.70) 958,003 (Expires June 18, 2019) ($0.36) 1,942,000 (Expires September 5, 2023) ($0.36) 1,935,427 (Expires September 21, 2023) ($0.36) 1,311,333 (Expires Octotber 25, 2023) ($0.36) 2,708,641 (Expires November 9, 2023) ($0.36) 710,200 (Expires November 30, 2023) ($0.36) 2,250,000 (Expires December 20, 2023) ($0.36) 4,820,000 (Expires January 17, 2024) ($0.36) 540,000 (Expires February 12, 2024) ($0.36) 2,123,188 (Expires February 21, 2024) ($0.36) 3,017,132 (Expires April 2, 2024) ($0.36) 1,325,000 (Expires May 6, 2024) Broker's Warrant ($0.25) (1) 180,000 (Expires December 20, 2023) ($0.25) (2) 359,800 (Expires January 17, 2024) ($0.25) (3) 125,264 (Expires February 21, 2024) Trading Symbol TSX.V: CVM OTCQB: CRRVF CUSIP# 126632108 ISIN# CA1266321084 AST Trust Company (Canada) 1600 – 1066 West Hastings St., Vancouver, BC V6E 3X1 Tel: 604-235-3701 Fax: 604-235-3705 Transfer Agent American Stock Transfer & Trust Company, LLC 6201 15th Avenue Brooklyn, New York 11219, U.S.A. Toll Free: 1.800.937.5449 Tel: 718.921.8124 Email: info@amstock.com Website: www.amstock.com Dallas Hack, CEO, CFO, Board Director IR Contact paulblunden@cvrmed.com Stay Informed - Sign Up for Updates & News About CVR Medical CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes. Follow Us Recent News CVR Medical Corp. Provides an Update on Restructuring Agreement and Severance Agreement with Former CEO CVR Medical Corp. Announces Reinstatement of Trading by the TSX-v and Delay in Filing of Annual and Interim Financial Statements and MD&A CVR Medical Corp. Announces Addition to Board of Directors CVR Medical Corp. Announces Additional Directors Twitter Feed CVR Medical Corp 3 years ago #CVRMedical receives IRB approval for Clinical Trial at Prestigious Mayo Clinic - Read More CVR Medical Corp 3 years ago @CVRMed submits CSS Device to FDA - Read More CVR Medical Corp 3 years ago CVR Medical announces closing of transaction with CVR Global - Read More Copyright © 2021 by CVR Medical Crop. | All Rights Reserved | Disclaimer | Website Designed by 702 Pros